Table 1

Disease activity parameters of 30 patients presented in our survey

	All patients (n=30)	REM: Patients adjudicated to REM state (n=21)	LDA: Patients adjudicated to LDA state (n=27)	MDA: Patients adjudicated to MDA state (n=17)	HDA: Patients adjudicated to HDA state (n=10)
Swollen joint count (SJC66)	1 (0/4)^§	0 (0/0)^§	1.0 (0/2.0)^§	4 (2/5)^§	7 (5/9)^§
Swollen joint count (SJC66)	0–14*	0–14*	0–7*	0–14*	1–14*
Tender joint count (TJC68)	2 (0/8)^§	0 (0/1)^§	1 (0/3)^§	8 (5/9)^§	12 (8/15)^§
Tender joint count (TJC68)	0–23*	0–23*	0–23*	0–23*	7–23*
Patient pain (PP; VAS)	28 (7/47)^§	4 (0/19)^§	27 (7/36)^§	47 (34/51)^§	60 (28/81)^§
Patient pain (PP; VAS)	0–94*	0–47*	0–81*	2–81*	13–94*
Patient global assessment (PtGA; VAS)	32 (7/63)^§	7 (5/17)^§	21 (7/36)^§	62 (32/67)^§	75 (54/80)^§
Patient global assessment (PtGA; VAS)	0–100*	0–70*	0–100*	5–100*	47–100*
C-reactive protein (CRP; mg/dL)	0.35 (0.17/0.7)^§	0.30 (0.17/0.82)^§	0.37 (0.18/0.60)^§	0.27 (0.10/0.35)^§	0.37 (0.35/0.99)^§
C-reactive protein (CRP; mg/dL)	0.08–5.88*	0.08–5.88*	0.08–5.88*	0.08–5.88*	0.17–5.54*
Psoriatic arthritis disease activity score (DAPSA)	10.1 (3.8/23.7)^§	2.7 (1.8/4.2)^§	9.6 (4.1/12.7)^§	22.3 (14.7/28.3)^§	36.5 (28.3/41.4)^§
Psoriatic arthritis disease activity score (DAPSA)	1.0–45.6*	1.0–45.6*	1.8–36.5*	4.1–45.6*	21.3–45.6*
Clinical DAPSA (cDAPSA)	8.8 (3.4/23.4)^§	2.3 (1.0/4.0)^§	6.7 (3.7/12.6)^§	22.0 (14.6/27.6)^§	33.3 (27.6/40.4)^§
	0.7–45.2*	0.7–45.2*	1.0–36.3*	3.7–45.2*	20.9–45.2*

Column ‘All patients’ specifies group-wise description of 30 patients. In Columns ‘REM’, ‘LDA’, ‘MDA’ and ‘HDA’, we present medians, 25th/75th percentiles (^§) and total range (minimum–maximum)* of patients classified to this state by expert rating. Note, that in the REM, LDA, MDA and HDA columns multiple observations of identical patients are included, if expert ratings for a specific patient diverged. VAS (0–100 mm); ^§median (and 25th/75th percentiles); *total range (minimum–maximum).
DAPSA, Disease Activity Index for Psoriatic Arthritis; HDA, high disease activity; LDA, low disease activity; MDA, moderate disease activity; REM, remission; VAS, Visual Analogue Scale.